Our report expands the landscape of oncogenic RAF1 aberrations in various solid cancers, and increasing the recognition of RAF1 aberrations in tumors will assist in further refining tumor classification and hopefully guide the management of patients with tumors bearing these alterations. Here, RAF1 is linked to neoplasm.